Betahistine
Top View
- Annexure-1 Patents Granted for Drugs (Products and Processes)
- Children (From 12 Months) (See Section Warnings and Precautions)
- How Stable Are Medicines Moved from Original Packs Into Compliance Aids?
- Atarax Hydroxyzine Hydrochloride Atarax 10 Mg Film-Coated Tablet Atarax 25 Mg Film-Coated Tablet Atarax 2 Mg/Ml Syrup [GSK Logo]
- EU Proposal Will Allow Production During
- Medicines and Falls Risk in Care Homes Commonly Prescribed Drugs That Can Contribute to Falls
- Current Views on Treatment of Vertigo and Dizziness
- Drug-Induced Diseases
- United States Patent (10) Patent N0.: US 6,692,768 B1 Ishibashi Et Al
- Bulletin 87 Is Currently Available for Download
- Atarax™ Hydroxyzine Hydrochloride Atarax™ 10 Mg Film-Coated Tablet Atarax™ 25 Mg Film-Coated Tablet Atarax™ 2 Mg/Ml Syrup
- Medicines and Falls in Hospital
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- Betahistine in the Treatment of Tinnitus in Patients with Vestibular Disorders
- Guideline on Medication and the Risk of Falling
- Possible Alternatives to Unlicensed 'Pharmaceutical Specials' For
- Cost Comparison Charts
- Summary of Product Characteristics 1. Name Of